神州细胞: 神州细胞2024年年度股东大会决议公告

Core Points - The company held a shareholders' meeting on May 16, 2025, in Beijing, where all proposed resolutions were approved without any objections [1][2][3] - A total of 88 ordinary shareholders attended the meeting, representing 349,644,425 voting rights, which accounts for 78.5125% of the company's total voting rights [1][2] - The meeting was conducted in accordance with the Company Law and the company's articles of association, with both onsite and online voting methods utilized [1][3] Voting Results - The resolutions were passed with overwhelming support, with the majority of votes in favor being 99.8799% for the first resolution, with only minor dissent [2][3] - The voting results for subsequent resolutions also showed high approval rates, with percentages consistently above 99% for ordinary shares [2][3] - The company confirmed that all voting procedures were valid and complied with legal requirements, as verified by the attending legal representatives [3]